Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, trips or professional assistance with a real medical doctor. We aren't docs. Always confer with your doctor about An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF Clinical research trials and An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF health trials happen in many of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectualness of new does drugs. The intention of the studies / projects is to figure out particular human healthcare questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to detect cures for all forms of circumstances, like An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF. An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the subjects get treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF clinical trial. Subjects frequently get the best healthcare possible for their An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF condition. Hazards are a reality, however, and could include more or frequent mD visits, health risks (possibly life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with exacting guidelines to protect clinical trials patients.

Home > "A" Clinical Trials Conditions > An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF

An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF



An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF

For Condition: Lung Disease,Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis
Status: No longer recruiting
Sponsor(s): InterMune ,
Synopsis: Open-label therapy will be administered to up to 220 patients, following completion of either InterMune Protocol GIPF-002 Part B or Protocol GIPF-004, to assess the long-term safety of subcutaneous Interferon gamma-1b. The study duration will be 5 years.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: - Enrollment in Protocol GIPF 002 Part B or GIPF-004 - Completion of the End of Treatment Visit in Protocol GIPF-002 Part B or the Study Completion Visit in GIPF-004 - Able to understand and sign a written informed consent form and comply with the requirements of the study
Total Enrollment: 220

Location and Contact Information:


Additional Information:
Study ID Numbers:
  GIPF-006; 
Study Start Date: November 2003
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00076635

Other Idiopathic Pulmonary Fibrosis Studies:
1. A study of the safety and efficacy Interferon-gamma 1b in patients with Idiopathic Pulmonary Fibrosis (IPF)

2. Safety and Tolerability Study of FG-3019 in Patients with Idiopathic Pulmonary Fibrosis

3. Efficacy and safety of oral bosentan in patients with Idiopathic Pulmonary Fibrosis

4. Pirfenidone for the Treatment of Patients with Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis (PF/IPF)

5. The INSPIRE Trial: A Study of Interferon gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)

Related Studies:

Other Idiopathic Pulmonary Fibrosis Clinical Trials
Other Clinical Trials
Other Clinical Trials

An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF

Modify your Search

  Other Idiopathic Pulmonary Fibrosis Clinical Trials
  Other Clinical Trials
  Other Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103